Status
Conditions
Treatments
About
The purpose of this study is to determine whether dasatinib is effective and safe in the treatment of refractory metastatic gastrointestinal stromal tumor
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
57 participants in 1 patient group
Loading...
Central trial contact
Li Jian
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal